Zhang L, Wang K, Liu R, Kuang T, Chen C, Yao F
Nutr J. 2024; 23(1):145.
PMID: 39548545
PMC: 11568527.
DOI: 10.1186/s12937-024-01037-w.
Cheng Z, Yang C, Zhao Q, Zhong J, Zhang J, Jin R
Cancer Sci. 2024; 115(6):1979-1988.
PMID: 38487949
PMC: 11145113.
DOI: 10.1111/cas.16142.
Kim M, Stroever S, Aploks K, Ostapenko A, Dong X, Seshadri R
World J Gastrointest Surg. 2024; 16(1):95-102.
PMID: 38328312
PMC: 10845287.
DOI: 10.4240/wjgs.v16.i1.95.
Pavlidis E, Galanis I, Pavlidis T
World J Gastrointest Oncol. 2024; 16(1):13-29.
PMID: 38292841
PMC: 10824116.
DOI: 10.4251/wjgo.v16.i1.13.
Zishan M, Tee C
BMJ Case Rep. 2023; 16(5).
PMID: 37236675
PMC: 10230927.
DOI: 10.1136/bcr-2023-254883.
NLRP3 inflammasome-induced pyroptosis in digestive system tumors.
Wen J, Xuan B, Liu Y, Wang L, He L, Meng X
Front Immunol. 2023; 14:1074606.
PMID: 37081882
PMC: 10110858.
DOI: 10.3389/fimmu.2023.1074606.
HSV: The scout and assault for digestive system tumors.
Li S, Li Q, Ren Y, Yi J, Guo J, Kong X
Front Mol Biosci. 2023; 10:1142498.
PMID: 36926680
PMC: 10011716.
DOI: 10.3389/fmolb.2023.1142498.
Multiparameter diagnostic model based on F-FDG PET metabolic parameters and clinical variables can differentiate nonmetastatic gallbladder cancer and cholecystitis.
Li C, Luan X, Bi X, Chen S, Pan Y, Zhang J
BMC Cancer. 2023; 23(1):119.
PMID: 36747196
PMC: 9901059.
DOI: 10.1186/s12885-023-10599-7.
Non-coding RNAs as potential biomarkers of gallbladder cancer.
Lv Y, Yin W, Zhang Z
Clin Transl Oncol. 2022; 25(6):1489-1511.
PMID: 36576705
DOI: 10.1007/s12094-022-03056-7.
Designing of Peptide Based Multi-Epitope Vaccine Construct against Gallbladder Cancer Using Immunoinformatics and Computational Approaches.
Dar M, Kumar P, Kumar P, Shrivastava A, Dar M, Chauhan R
Vaccines (Basel). 2022; 10(11).
PMID: 36366359
PMC: 9696659.
DOI: 10.3390/vaccines10111850.
Combined hepatocellular carcinoma-cholangiocarcinoma in a patient with Fontan-associated liver disease.
Jou J, Li J, Kaldas F
BMJ Case Rep. 2022; 15(11).
PMID: 36343983
PMC: 9644299.
DOI: 10.1136/bcr-2022-250590.
Gallbladder cancer.
Roa J, Garcia P, Kapoor V, Maithel S, Javle M, Koshiol J
Nat Rev Dis Primers. 2022; 8(1):69.
PMID: 36302789
DOI: 10.1038/s41572-022-00398-y.
Cost-Effectiveness Analysis of Capecitabine Plus Oxaliplatin Versus Gemcitabine Plus Oxaliplatin as First-Line Therapy for Advanced Biliary Tract Cancers.
Chen R, Zhang Y, Lin K, Huang D, You M, Lai Y
Front Pharmacol. 2022; 13:871262.
PMID: 35935821
PMC: 9354395.
DOI: 10.3389/fphar.2022.871262.
Carcinosarcoma with chondroid differentiation and neuroendocrine carcinoma: unusual triphasic tumour arising from intracholecystic papillary neoplasm of the gall bladder.
Mruthyunjayappa S, Patel C, Reddy S, Al Diffalha S
BMJ Case Rep. 2022; 15(7).
PMID: 35858746
PMC: 9305697.
DOI: 10.1136/bcr-2021-245555.
Surgery in combination with systemic chemotherapy is associated with improved survival in stage IV gallbladder cancer.
Casabianca A, Tsagkalidis V, Burchard P, Chacon A, Melucci A, Reitz A
Eur J Surg Oncol. 2022; 48(12):2448-2454.
PMID: 35773092
PMC: 10993821.
DOI: 10.1016/j.ejso.2022.06.029.
Age-specific clinicopathological characteristics and prognostic analysis of neuroendocrine carcinomas of the gallbladder.
Zhang Z, Guo T, Huang X, Xie P, Wang L, Yu Y
Cancer Med. 2021; 11(3):641-653.
PMID: 34841738
PMC: 8817078.
DOI: 10.1002/cam4.4463.
Neoadjuvant Chemotherapy for Advanced Gallbladder Cancer: Do We have Enough Evidence? A Systematic Review.
Naveed S, Qari H, Thau C, Burasakarn P, Mir A
Euroasian J Hepatogastroenterol. 2021; 11(2):87-94.
PMID: 34786362
PMC: 8566156.
DOI: 10.5005/jp-journals-10018-1348.
Gallbladder cancer: Historical treatment and new management options.
Okumura K, Gogna S, Gachabayov M, Felsenreich D, McGuirk M, Rojas A
World J Gastrointest Oncol. 2021; 13(10):1317-1335.
PMID: 34721769
PMC: 8529935.
DOI: 10.4251/wjgo.v13.i10.1317.
The State of Immunotherapy in Hepatobiliary Cancers.
Ilyas F, Beane J, Pawlik T
Cells. 2021; 10(8).
PMID: 34440865
PMC: 8393650.
DOI: 10.3390/cells10082096.
Perioperative Versus Adjuvant Chemotherapy in the Management of Incidentally Found Gallbladder Cancer (OPT-IN).
Khan T, Verbus E, Hong H, Ethun C, Maithel S, Hernandez J
Ann Surg Oncol. 2021; 29(1):37-38.
PMID: 34132951
DOI: 10.1245/s10434-021-10277-7.